EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Multimodal Assessment of Therapeutic Drug Resistance in OVCAR4 High Grade Serous Ovarian Carcinoma (HGSOC) Cells

Faisal Iqbal

Proceedings · 08.07.2026 · 40 (2) · 143-153

DOI: 10.47489/szmc.v40i2.899 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings, online erschienen am 08.07.2026. Verfasst von Faisal Iqbal. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Drug resistance is a major challenge for the treatment of high-grade serous ovarian carcinoma (HGSOC), frequently leading to disease recurrence and therapeutic failure.

Objective

This study investigated the cellular phenotypic and molecular bases of drug resistance in human ovarian cancer cell line such as OVCAR4.

Method

The chlorpromazine (CPZ) and metformin repurposed drugs were used for the treatment of ovarian cancer cells to follow the treatment response, and the hemocytometer and clonogenic assay were used, followed by the ANOVA and Tukey’s HSD post hoc test for statistical analysis. Surviving cell populations were recognized as drug resistant and further analysed at the molecular level. The OVCAR4 cells were used for RNA isolation and then converted into cDNA and used for real-time PCR, and PCR amplicons were verified by gel electrophoresis Results: The molecular results were linked to the observable outcomes from the hemocytometer and clonogenic assay after drug treatment.

Conclusion

The research study provides a drug resistance-related inclusive analysis in ovarian cancer. Cellular and molecular analyses provide in vitro identification of resistance-associated markers and open a future path for therapeutic approaches to overcome drug resistance in ovarian cancer.

Zitieren

APA

Iqbal, F. (2026). Multimodal Assessment of Therapeutic Drug Resistance in OVCAR4 High Grade Serous Ovarian Carcinoma (HGSOC) Cells. Proceedings, 40(2), 143-153. https://doi.org/10.47489/szmc.v40i2.899

Vancouver

Iqbal F. Multimodal Assessment of Therapeutic Drug Resistance in OVCAR4 High Grade Serous Ovarian Carcinoma (HGSOC) Cells. Proceedings. 2026;40(2):143-153. doi:10.47489/szmc.v40i2.899

BibTeX
@article{Iqbal2026,
  author = {Iqbal, Faisal},
  title = {Multimodal Assessment of Therapeutic Drug Resistance in OVCAR4 High Grade Serous Ovarian Carcinoma (HGSOC) Cells},
  journal = {Proceedings},
  year = {2026},
  volume = {40},
  number = {2},
  pages = {143--153},
  doi = {10.47489/szmc.v40i2.899}
}
Kostenlos starten →